BioHarvest Sciences Inc.
BHSC
CNSX
| Weiss Ratings | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.76 | |||
| Price History | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $10.50 | |||
| 52-Week Low Price | $6.24 | |||
| 52-Week Low Price (Date) | Oct 29, 2024 | |||
| 52-Week High Price (Date) | Mar 19, 2024 | |||
| Valuation | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 104.63M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.19 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 6.15 | |||
| Price/Book (Q) | 33.28 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 17.34M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 622 1186 | |||
| Address | 1140-625 Howe Street Vancouver, BC V6C 2T6 | |||
| Website | www.bioharvest.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -35.00% | |||
| Profit Margin | -76.64% | |||
| Management Effectiveness | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -26.95% | |||
| Return on Equity | -- | |||
| Income Statement | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 22.43M | |||
| Total Revenue (TTM) | 22.43M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 12.11M | |||
| EBITDA (TTM) | -6.84M | |||
| EBIT (TTM) | -7.85M | |||
| Net Income (TTM) | -17.19M | |||
| Net Income Avl. to Common (TTM) | -17.19M | |||
| Total Revenue Growth (Q YOY) | 101.88% | |||
| Earnings Growth (Q YOY) | -55.70% | |||
| EPS Diluted (TTM) | -1.19 | |||
| EPS Diluted Growth (Q YOY) | -20.51% | |||
| Balance Sheet | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.77M | |||
| Cash Per Share (Q) | $0.16 | |||
| Total Current Assets (Q) | 7.98M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.14M | |||
| Current Ratio (Q) | 0.804 | |||
| Book Value Per Share (Q) | $0.24 | |||
| Total Assets (Q) | 25.82M | |||
| Total Current Liabilities (Q) | 9.93M | |||
| Total Debt (Q) | 10.70M | |||
| Total Liabilities (Q) | 21.68M | |||
| Total Common Equity (Q) | 4.14M | |||
| Cash Flow | BHSC - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.92M | |||
| Cash from Financing (TTM) | 11.34M | |||
| Net Change in Cash (TTM) | 1.21M | |||
| Levered Free Cash Flow (TTM) | -8.05M | |||
| Cash from Operations (TTM) | -7.29M | |||
